Dr Kamal Dua is an award-winning pharmaceutics and drug delivery researcher who has deep roots in teaching, research and industry spanning three nations and two continents. He holds two doctoral degrees in Pharmaceutical Sciences and Immunology & Microbiology, and has also completed four professional diplomas in the areas of clinical research, product development, drug regulation, and documentation and intellectual property rights.

In his role as an Associate Professor in the Graduate School of Health at UTS, Dr Dua alongside teaching in the Pharmacy program, also leads a suite of Good Manufacturing Practice (GMP) courses where, as a Program Coordinator, his responsibilities include coordinating the academic and research activities for those courses.

Drawing on his experience with various pharmacy schools in Australia and overseas, Dr Dua has blended different modes of innovative teaching with traditional teaching modes to create a flexible, student-centred and engaging approach to pedagogy.

Dr Dua is also an Adjunct Professor, Faculty of Pharmacy & Pharmaceutical Sciences, University of Alberta, Canada; Core member, Australian Research Centre in Complementary and Integrative Medicine (ARCCIM), UTS; Adjunct Professor, National Centre for Naturopathic Medicine (NCNM), Southern Cross University, Australia; Adjunct Senior Lecturer, International Medical University and Taylor's University, Malaysia; Adjunct Faculty, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, India and Research Associate at the Australia-China Relations Institute (UTS:ACRI). He also held a Conjoint Lecturer position with the School of Biomedical Sciences and Pharmacy, The University of Newcastle, Australia and Adjunct Fellow, NICM Health Research Institute, Western Sydney University, Australia.

Dr Dua’s collaborations include working with Dr Michael John Rathbone, former Professor and Dean, School of Pharmacy, at the International Medical University in Malaysia, and founder of ULTI Pharmaceuticals, a veterinary pharmaceutical company based in New Zealand. Kamal is associated as a consultant on quality systems management and GMP for ULTI Pharmaceuticals.

Dr Dua’s academic research has contributed significantly to the field of managing chronic inflammatory diseases, especially airway diseases, using novel nano-carriers to deliver potential therapeutic molecules, including phytoconstituents. His research involves identifying potential key targets regulating the pathophysiology of the disease and formulating them into effective drug delivery systems that could be translated to clinical settings.

Dr Dua has been recognised and named as one of Australia’s Top 250 researchers in 2024, 2025 and 2026 by The Australian's Research Magazine. Dr Dua was ranked #1 in Pharmacology & Pharmacy in 2026 & 2025, and in Toxicology in 2024, respectively, within the research discipline of Health and Medical Sciences, a testament to the excellence of the research undertaken. The award is based on the number of citations for papers published in the top 20 journals in each field over the past five years. Dr Dua has been prolific with his publications to date in top-ranking journals and has built a strong local and international collaboration network as part of that. Moreover, in 2025, Dr Dua was honoured to be selected as a finalist for the New South Wales (NSW) Premier’s Prizes for Science & Engineering in the category of Excellence in Medical Biological Sciences (cell and molecular biology, medical, veterinary, and genetics). This prestigious recognition reflects the significant impact and translational potential of his research in advancing biomedical science within both academic and applied settings.

To date, his research has resulted in more than 190 peer-reviewed publications in various recognised pharmacy and pharmacology journals, with citations exceeding 16,000. He has also presented his research at more than 100 national and international conferences, published more than 70 book chapters, and eleven books on issues ranging from drug delivery and pathophysiological mechanisms underlying respiratory diseases, to cancer.

Dr Dua’s work has been recognised by various awards and fellowships including the Faculty of Health Dean’s Academic Excellence Award for Faculty Engagement (2023, 2019), Excellence Award in Pharmacy (2018), Young Scientist Award (2011), International Association for Dental Research Southeast Asian Division (IADR SEA); Dentsply Student Clinician Program Award (2014); the Educational Workshop Fellowship/Travel award by the World Society for Paediatric Infectious Diseases - WSPID (2011 and 2013); and the Sri. K. Sri Harsha Memorial Gold Medal and Rank Certificate (2004).